急性心肌梗死合并心源性休克患者中血管活性正性肌力评分对预后的预测价值因机械循环支持使用与否而异
该多中心回顾性及前瞻性观察性队列研究纳入韩国12个中心共836例急性心肌梗死合并心源性休克患者,按血管活性正性肌力评分四分位数分组(<10、10-30、30-90、>90)。主要终点为院内死亡率,随评分升高而显著增加(15.6%、20.8%、40.2%、67.3%;p<0.001)。血管活性正性肌力评分预测院内死亡的AUC在仅药物治疗组为0.797(95%CI 0.728-0.865),高于IABP组0.704(95%CI 0.625-0.783)和ECMO组0.644(95%CI 0.580-0.709);最佳截断值分别为16.5、40.1和84.0。评分与机械循环支持使用对随访全因死亡存在显著交互作用。
要点
- 在急性心肌梗死合并心源性休克患者中,血管活性正性肌力评分越高,院内死亡率越高(<10、10-30、30-90、>90组分别为15.6%、20.8%、40.2%、67.3%;p<0.001)。
- 血管活性正性肌力评分预测院内死亡的AUC在仅药物治疗组为0.797(95%CI 0.728-0.865),优于IABP组0.704(95%CI 0.625-0.783)和ECMO组0.644(95%CI 0.580-0.709)。
- 预测院内死亡的最佳截断值因是否使用机械循环支持而异:仅药物治疗组16.5、IABP组40.1、ECMO组84.0。
- 血管活性正性肌力评分与机械循环支持(IABP交互p=0.006,ECMO交互p<0.001)对随访全因死亡存在显著交互作用。
- 该研究为观察性队列,血管活性正性肌力评分的预测价值需前瞻性验证,不能直接作为治疗决策阈值。
适用人群与场景
- 韩国12个中心REtrospective and prospective observational Study to investigate Clinical oUtcomes and Efficacy注册研究中1247例心源性休克患者,最终纳入836例急性心肌梗死合并心源性休克患者。
- 研究人群按血管活性正性肌力评分四分位数分层:<10、10-30、30-90、>90。
- 其中326例(39.0%)仅接受药物治疗,218例(26.1%)接受主动脉内球囊反搏(IABP),292例(34.9%)接受体外膜肺氧合(ECMO)。
诊断标准与关键阈值
- 原文未提及心源性休克或急性心肌梗死的具体诊断标准。
- 血管活性正性肌力评分分组界值:<10、10-30、30-90、>90。
- 预测院内死亡的最佳截断值:仅药物治疗组16.5,IABP组40.1,ECMO组84.0。
处置流程与药物剂量
- 原文未提及具体治疗药物、剂量、给药途径或流程。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究设计:多中心回顾性及前瞻性观察性队列研究,韩国12个中心,836例急性心肌梗死合并心源性休克患者。
- 主要终点院内死亡305例(36.5%),血管活性正性肌力评分越高院内死亡率越高(<10、10-30、30-90、>90组分别为15.6%、20.8%、40.2%、67.3%;p<0.001)。
- 血管活性正性肌力评分预测院内死亡的AUC:仅药物治疗组0.797(95%CI 0.728-0.865),IABP组0.704(95%CI 0.625-0.783),ECMO组0.644(95%CI 0.580-0.709)。
- 预测院内死亡最佳截断值:仅药物治疗组16.5,IABP组40.1,ECMO组84.0。
- 血管活性正性肌力评分(连续值)与机械循环支持对随访全因死亡存在显著交互作用:IABP交互p=0.006,ECMO交互p<0.001。
证据类型、等级与局限
- 证据类型:多中心回顾性及前瞻性观察性队列研究。
- 局限:观察性设计,原文未提及盲法或混杂控制细节,样本来自韩国12个中心,结果需前瞻性验证。
对床旁实践的改变
- 在急性心肌梗死合并心源性休克患者中,血管活性正性肌力评分可用于风险分层,但应结合是否使用机械循环支持解读:仅药物治疗者评分预测价值较高,使用IABP或ECMO者预测价值降低。
- 不能将本研究的截断值(16.5、40.1、84.0)直接作为启动或停止机械循环支持的决策阈值,因研究为观察性设计且截断值为预测院内死亡的最佳值而非治疗阈值。
- 血管活性正性肌力评分与机械循环支持对随访死亡存在交互作用,提示在使用机械循环支持的患者中单纯依赖该评分评估预后可能不可靠。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To identify whether the prognostic implications of Vasoactive Inotropic Score according to use of mechanical circulatory support differ in the treatment of acute myocardial infarction complicated by cardiogenic shock.
DESIGN: A multicenter retrospective and prospective observational cohort study.
SETTING/PATIENT: The REtrospective and prospective observational Study to investigate Clinical oUtcomes and Efficacy registry includes 1,247 patients with cardiogenic shock from 12 centers in Korea. A total of 836 patients with acute myocardial infarction complicated by cardiogenic shock were finally selected, and the study population was stratified by quartiles of Vasoactive Inotropic Score (< 10, 10-30, 30-90, and > 90) for the present study.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Primary endpoint was in-hospital mortality and secondary endpoint was follow-up mortality. Among the study population, 326 patients (39.0%) received medical treatment alone, 218 (26.1%) received intra-aortic balloon pump, and 292 (34.9%) received extracorporeal membrane oxygenation. In-hospital mortality occurred in 305 patients (36.5%) and was significantly higher in patients with higher Vasoactive Inotropic Score (15.6%, 20.8%, 40.2%, and 67.3%, for < 10, 10-30, 30-90, and > 90; p < 0.001). Vasoactive Inotropic Score showed better ability to predict in-hospital mortality in acute myocardial infarction patients with cardiogenic shock who received medical treatment alone (area under the curve: 0.797; 95% CI, 0.728-0.865) than in those who received intra-aortic balloon pump (area under the curve, 0.704; 95% CI, 0.625-0.783) or extracorporeal membrane oxygenation (area under the curve, 0.644; 95% CI, 0.580-0.709). The best cutoff value of Vasoactive Inotropic Score for the prediction of in-hospital mortality also differed according to the use of mechanical circulatory support (16.5, 40.1, and 84.0 for medical treatment alone, intra-aortic balloon pump, and extracorporeal membrane oxygenation, respectively). There was a significant interaction between Vasoactive Inotropic Score as a continuous value and the use of mechanical circulatory support including intra-aortic balloon pump (interaction-p = 0.006) and extracorporeal membrane oxygenation (interaction-p < 0.001) for all-cause mortality during follow-up.
CONCLUSIONS: High Vasoactive Inotropic Score was associated with significantly higher in-hospital and follow-up mortality in patients with acute myocardial infarction complicated by cardiogenic shock. The predictive value of Vasoactive Inotropic Score for mortality was significantly higher in acute myocardial infarction patients with cardiogenic shock treated by medical treatment alone than in those treated by mechanical circulatory support such as intra-aortic balloon pump or extracorporeal membrane oxygenation.
参考来源
- Choi KH, Yang JH, Park TK, et al. Differential Prognostic Implications of Vasoactive Inotropic Score for Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock According to Use of Mechanical Circulatory Support. Crit Care Med. 2021. PMID: 33590998. doi:10.1097/CCM.0000000000004815
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。